Venom-producing snake organoids developed in the lab
News
23 January 2020
Venom-producing snake organoids developed in the lab
Researchers from the group of Oncode Investigator Hans Clevers, together with Oncode Investigators Anne Rios, Alexander van Oudenaarden and many others, have developed a method to grow snake venom gland cells as organoids. These lab-grown mini glands produce and secrete active toxins found in snake venom. Snake venom gland organoids can be grown from multiple species and maintained in the lab indefinitely. This new technology holds great promise to reduce the devastating impact and exploit the secrets of snake venom. The results of this research were published in the scientific journal Cell on the 23rd of January.
ElizeBrolsma
Some subtypes of gastric/oesophageal adenocarcinoma responsive to immunotherapy
Story
Some subtypes of gastric/oesophageal adenocarcinoma responsive to immunotherapy
Interview with medical oncologist and Oncode Investigator Dr Sarah Derks. Gastric and oesophageal adenocarcinomas are a heterogeneous group, so it should come as no surprise that not all subtypes of gastric and oesophageal adenocarcinoma respond equally well to immunotherapy. Sarah explains why tumours that test positive for the Epstein-Barr virus and tumours with microsatellite instability are particularly responsive to immune checkpoint inhibitors.
ElizeBrolsma
Tumour microenvironment & Immunology
Event
Tumour microenvironment & Immunology
We would like to invite you to the 2-day theme meeting on Tumour microenvironment & Immunology. We will start on Monday February 10th at 10.00 and expect to finish on the 11th of February at 15:00. We are proud to annouce the amazing speakers, including key note speaker Professor Victoria Sanz-Moreno, Barts Cancer Institute, London.
ElizeBrolsma
EU invests 10 million euro in unlocking technologies for key research in structural biology
News
17 December 2019
EU invests 10 million euro in unlocking technologies for key research in structural biology
To enable researchers from European institutes to extend innovative structural biology research, the EU has invested 10 million euro to iNEXT-Discovery, through its Horizon 2020 program.
Vesnade Jong
Oncode Investigators Elzo de Wit and Ruben van Boxtel receive ERC Grant
News
10 December 2019
Oncode Investigators Elzo de Wit and Ruben van Boxtel receive ERC Grant
Oncode Institute is proud to announce that Oncode Investigators Elzo de Wit (Netherlands Cancer Institute) and Ruben van Boxtel (Princess Máxima Center) both receive the ERC Consolidator Grant. The ERC Consolidator Grants are awarded to outstanding researchers with at least seven and up to twelve years of experience after PhD, and a scientific track record showing great promise.
ElizeBrolsma

Meet Oncode

Fundamental science, clinical testing and a sharp mind for market opportunities: at Oncode we bring it all together to create impact for patients.
https://www.oncode.nl/about/in-het-nederlands
About
In het Nederlands
Oncode is een internationale organisatie. Maar gezien onze oorsprong vertellen we ons verhaal ook graag in het Nederlands.
https://www.oncode.nl/about/founding-principles
About
Our founding principles
We want to understand cancer - but that's only the start. Discover what Oncode stands for in 9 statements.
https://www.oncode.nl/about
About
Getting acquainted
Whether you're looking for a chart or contact information, and whether you're a PhD, a partner or a patient: pleased to meet you.
Valorization
Speeding-up the processes
How can we bring effective and affordable technologies to patients faster? Read about this and other concerns in our valorization strategy.